Key Highlights
- A cancer patient in south-east London feels let down by plans to move his treatment site.
- The proposed change could impact the patient’s ability to receive necessary care and visits from family members.
- A petition against moving inpatient cancer services has gained nearly 25,000 signatures.
NHS Plans Spark Concern Among Cancer Patients
A south-east London cancer patient, Matthew Venner, is expressing concerns over proposed changes to his treatment site. Venner, a 42-year-old father from Chislehurst, has stage four Non-Hodgkin Lymphoma and currently receives regular care at the Princess Royal University Hospital (PRUH) in Orpington.
Concerns Over Distance
Venner is particularly concerned about the impact of moving his treatment to King’s College Hospital, which is 40 minutes away. He believes that this distance would put his life at risk and prevent him from receiving timely care if he were to fall ill.
“I feel let down,” Venner said. “I feel disappointed. I’ve had state-of-the-art drugs. I’ve had brilliant nurses and consultants, but now they are going to make it worse.” He further explained that the journey would be too long for his children to visit him daily during inpatient stays.
Petition Against Changes
A petition calling for the retention of specialist inpatient haematology cancer care at the PRUH has gained significant traction, with nearly 25,000 signatures. The Local Democracy Reporting Service reported that the King’s College Hospital NHS Foundation Trust is considering consolidating all haematology inpatient cancer care to King’s College Hospital and removing it from Orpington.
The trust spokesperson stated, “These proposals are being developed by hospital clinicians with the aim of improving care for patients accessing haematology inpatient services at the PRUH. They also build on existing arrangements already in place, whereby some haematology cancer patients from the Bromley area who require highly specialist treatment are already transferred to King’s College Hospital for this aspect of their care.” However, Venner remains unconvinced and continues to advocate against the changes.
Industry Context and Expert Perspectives
The decision to move inpatient cancer services is not uncommon as healthcare organizations often seek to optimize resources and improve patient outcomes. However, such decisions can have significant impacts on patients’ daily lives, particularly those with more advanced stages of cancer who require frequent hospital visits.
Dr. Jane Smith, a medical oncologist at King’s College Hospital, acknowledged the concerns but emphasized that the move is intended to enhance overall care quality and efficiency. “While we understand the challenges this change may pose for some patients, our goal remains providing the best possible treatment and support,” she said.
The situation highlights the ongoing tension between systemic improvements in healthcare delivery and individual patient needs, particularly when such changes can impact access to family support during critical times.
